Oncology & Cancer
Lymphoma survivors may not get all recommended follow-up care
(HealthDay)—Some teen and young adult survivors of Hodgkin lymphoma do not receive all the recommended follow-up care, a new study finds.
Jan 15, 2016
0
9
Lymphoma
Oncology & Cancer
Long-term survivors of childhood cancer living longer thanks in part to treatment changes
Evidence from the Childhood Cancer Survivor Study (CCSS) suggests that changes in childhood cancer treatment and follow-up care have reduced deaths from the late effects of cancer treatment and extended the lives of childhood ...
Jan 13, 2016
0
5
Oncology & Cancer
Unravelling the causes of an aggressive childhood cancer
The origins of a type of aggressive childhood lymphoma have been found, giving hope that new drugs could be designed to prevent the disease coming back after treatment.
Jan 13, 2016
0
111
HIV & AIDS
Disparity lies at intersection of HIV, Hodgkin lymphoma
A new study finds a significant racial disparity within a doubly troubled population of patients: those with HIV and Hodgkin lymphoma. In such cases, blacks are at significantly higher risk than whites of not receiving treatment ...
Jan 8, 2016
0
9
Oncology & Cancer
Second cancer risk persists for Hodgkin's lymphoma survivors
(HealthDay)—Hodgkin's lymphoma survivors have an increased risk of a second cancer, with risk still elevated at 35 years or more after treatment, according to a study published in the Dec. 24 issue of the New England Journal ...
Dec 29, 2015
0
2
Oncology & Cancer
New target for potential blood cancer treatment
Mutations present in a blood cancer known as follicular lymphoma have revealed new molecular targets for potential treatments, according to researchers at Queen Mary University of London (QMUL) together with collaborators ...
Dec 21, 2015
1
6
Oncology & Cancer
Pregnancy does not increase risk of Hodgkin lymphoma recurrence
Pregnancy does not increase the risk of relapse among women successfully treated for Hodgkin lymphoma. This according to a new study from Sweden's Karolinska Institutet and Uppsala University published in The Journal of Clinical ...
Dec 15, 2015
0
1
Oncology & Cancer
High response rates, long-term remissions in Penn trials of personalized cell therapy
Ninety-three percent of pediatric patients (55 of 59) with relapsed/refractory acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy made from their own immune cells, with continuous ...
Dec 7, 2015
0
0
Oncology & Cancer
Late effects of treatment study continues sustained academic effort in Hodgkin's lymphoma
Early diagnosis, targeted therapeutics, and more personalized multimodal treatments have boosted survival rates of patients with cancer and have led to a large and rapidly increasing number of cancer survivors. This is particularly ...
Nov 18, 2015
0
4
Oncology & Cancer
Lenalidomide plus rituximab produces durable responses in mantle cell lymphoma patients
New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma. The results from ...
Nov 12, 2015
0
10
